{"symbol":"ABT","fiscalQuarter":"Q2-2021","reportDate":"2021-07-22","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2021","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 0.6%","keyNumbers":[{"metric":"EPS","actual":"$1.17","expected":"N/A","surprise":"+16.19%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported an EPS of $1.17, exceeding expectations by 16.19%. However, the stock reacted negatively, declining by 0.6%. This suggests that despite the earnings beat, investors may have had concerns about other aspects of the company's performance or future outlook.","metaDescription":"Abbott Laboratories (ABT) Q2 2021 earnings: EPS beat by 16.19%. Stock down 0.6%. Full breakdown."}}